Raymond Cheong
Direktor/Vorstandsmitglied bei TALIS BIOMEDICAL CORPORATION
Vermögen: 465 734 $ am 30.04.2024
Aktive Positionen von Raymond Cheong
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TALIS BIOMEDICAL CORPORATION | Direktor/Vorstandsmitglied | 10.03.2023 | - |
| MADRIGAL PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 15.06.2023 | - |
| VTV THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 27.02.2024 | - |
| Independent Dir/Board Member | 27.02.2024 | - | |
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Direktor/Vorstandsmitglied | 01.12.2018 | - |
Karriereverlauf von Raymond Cheong
Ehemalige bekannte Positionen von Raymond Cheong
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TALIS BIOMEDICAL CORPORATION | Direktor/Vorstandsmitglied | 01.06.2020 | 10.06.2022 |
Ausbildung von Raymond Cheong
| University of Maryland | Undergraduate Degree |
| The Johns Hopkins University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Director/Board Member | 5 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| TALIS BIOMEDICAL CORPORATION | Health Technology |
| MADRIGAL PHARMACEUTICALS, INC. | Health Technology |
| VTV THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Health Technology |
- Börse
- Insiders
- Raymond Cheong
- Erfahrung
